LSD1-IN-30

CAS No. 1289575-45-6

LSD1-IN-30( —— )

Catalog No. M37358 CAS No. 1289575-45-6

LSD1-IN-30 is a lysine-specific demethylase 1 (LSD1) inhibitor with anticancer activity for the study of small cell lung cancer and acute myeloid leukemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 179 Get Quote
5MG 282 Get Quote
10MG 451 Get Quote
25MG 877 Get Quote
50MG 1408 Get Quote
100MG 2205 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LSD1-IN-30
  • Note
    Research use only, not for human use.
  • Brief Description
    LSD1-IN-30 is a lysine-specific demethylase 1 (LSD1) inhibitor with anticancer activity for the study of small cell lung cancer and acute myeloid leukemia.
  • Description
    LSD1-IN-30 (compound 3) is a potent inhibitor of lysine-specific demethylase 1 (LSD1), with the IC50 value of 0.291 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    Histone Demethylase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1289575-45-6
  • Formula Weight
    270.28
  • Molecular Formula
    C15H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (369.99 mM; Ultrasonic )
  • SMILES
    C(=N\NC(=O)C1=CC=C(O)C=C1)(\C)/C2=C(O)C=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Venkataswamy Sorna, et al. High-Throughput Virtual Screening Identifies Novel N′?(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors. J Med Chem. 2013 Dec 12;56(23):9496-508.?
molnova catalog
related products
  • SD49-7

    SD49-7 is an inhibitor of histone lysine demethylase 4 (KDM4) with an IC50 of 0.19 μM.

  • E67-2

    E67-2 is a potent and selective inhibitor of H3K9 Jumonji demethylase KIAA1718 (KDM7A) with IC50 of 3.4 uM.

  • KDM5-IN-48

    A potent, selective and orally bioavailable KDM5 inhibitor with biochemical IC50 of 15.1, 4.7 and 65.5 nM for KDM5A, KDM5B and KDM5C, respectively.